Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints By Reuters Economy December 20, 2024 By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN(Reuters) -Novo Nordisk said on Friday its experimental next-generation obesity drug CagriSema helped patients…